Microcirculation in the Diabetic Foot: An Update I t has been nearly half a century since Goldenberg et al 1 erroneously declared occlusive microvascular disease of the small and medium sized arterioles to be the hallmark of peripheral vascular disease in diabetes. As a result, atherosclerosis of the small vessels was deemed the culprit behind ischemic lesions and impairment of wound healing. This idea of "small vessel disease" proliferated, leading to a pessimistic view of arterial reconstruction in the diabetic population. As a result, amputations were often considered the treatment of choice, possibly resulting in many unnecessary limb amputations.
Since then, a number of studies have refuted the concept of "small vessel disease." Influential studies by LoGerfo, 2 Strandness, 3 Conrad, 4 and Barner et al 5 vehemently disputed the notion that the small vessels are preferentially affected by atherosclerotic occlusive disease. Instead, atherosclerosis was found to affect the large vessels in both diabetic and nondiabetics in a similar fashion histologically. These findings dramatically changed the treatment options offered to the diabetic patient with an ischemic foot ulcer. Subsequently, the number of arterial reconstructions in diabetic patients increased and this in turn led to a drop in the number of major amputations performed.
Fast forward 50 years, and the specter of small vessel disease has manifested itself once again. However, in lieu of an occlusive disease described by Goldenberg, this small vessel disease is characterized by a nonocclusive dysfunction of the capillaries and arterioles (comprising the microcirculation), resulting in diminished vascular reactivity, endothelial dysfunction, and impaired wound healing. In contrast to macrovascular disease, the morphological changes and cellular dysfunction observed in the microcirculation is relatively unique to diabetes.
Although it is well known by now that an occlusive lesion is not present in the diabetic microcirculation, structural changes do exist. The most notable change involves thickening of the basement membrane, possibly acting as a barrier to the exchange of nutrients and activated cellular activity. However, it is important to point out that thickening of the basement membrane does not lead to narrowing of the capillary lumen, nor does it affect the blood flow. 6 Recent technological advances over the last decade have enabled us to evaluate the functional microcirculation of the feet. Methods such as laser Doppler flowmetry, flow-video microscopy, cannulation measurements of capillary pressure, and transcutaneous oxygen tension measurements have all been used. The most commonly used technique, and the one used in our lab, for evaluating blood flow in the skin remains laser Doppler flowmetry. Laser Doppler flowmetry uses capillary flux to measure the superficial microvascular perfusion. In conjunction with iontophoresis (this technique involves the delivery of a vasoactive substance to a localized area of skin) of acetylcholine or sodium nitroprusside, the endothelium-dependent vasodilation and endothelium-independent microvascular reactivity can be determined. This technique has been validated against direct measurements of the capillary flow velocity and has been shown to have a day-to-day reproducibility from measurements in our lab. 7 As discussed, laser Doppler flowmetry in conjunction with iontophoresis has enabled measurement of endothelial vasodilation. Work from our unit has identified that both the endothelium-dependent vasodilation and the independent vasodilation (a function of the vascular smooth muscle) is lowered at both the foot and forearm level in diabetic patients. Furthermore, this diminishment appears to be closely related to the presence of diabetic peripheral neuropathy.
It is also currently understood that changes in the nerve function also affect the skin blood flow. Under normal circumstances, stimulation of C-nociceptive fibers leads to retrograde stimulation of adjacent fibers, causing vasodilation and increased blood flow to the injured tissues, thereby promoting wound healing. This is also known as Lewis' triple flare response. This response is typically equal to one third of the maximal vasodilatory capacity and is responsible for the hyperemic response in areas of injury. In the diabetic neuropathic patient, this response is nearly absent, providing a plausible explanation for the clinically observed lack of hyperemia in the infected or injured diabetic foot.
Recent work from our unit has also shed light on the role of poly (ADP-ribose) polymerase (PARP) in endothelial function. 8 PARP activation was associated with decreased vascular reactivity in the microcirculation. Interestingly, PARP activation was found in diabetic patients as well as those healthy patients at risk for developing diabetes. This finding demonstrates that changes in the microcirculation may begin in the prediabetic state.
All of these changes in the microcirculation appear to affect wound healing by failing to provide the vasodilation and hyperemia necessary for normal wound healing. Despite the lack of complete understanding of the involved mechanisms, the main understanding from work conducted over the past decade has shown that the microcirculation of the diabetic neuropathic foot fails to maximally vasodilate under conditions of stress. Thus, even in the absence of any peripheral disease and in the presence of good blood flow in the large vessels, the skin blood flow is impaired when injury occurs, and this is thought to be one of the major factors related to impaired wound healing.
In conclusion, there is a growing body of evidence that impairments at the microvascular level play a major role in the impaired wound healing observed in diabetes. Although the idea of an occlusive microvascular disease in diabetes may be regarded as obsolete, there clearly remains a "functional microvascular disease." Further investigation into this promising area of research may prove to shape developing treatments in the years to come.
